Literature DB >> 3115870

Cholestasis and liver failure with lambda-AL amyloidosis.

F Konikoff1, C Mor, S Stern, M Shaklai, J Halevy, E Theodor.   

Abstract

Clinically significant liver involvement in systemic amyloidosis, especially with cholestasis, is rare. We report a case of primary amyloidosis with severe intrahepatic cholestasis leading to terminal liver failure. The present case is the first of its kind reported involving Lambda light chains only as the associated paraprotein. Conventional treatment and a therapeutic trial with dimethyl sulphoxide were unsuccessful.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3115870      PMCID: PMC1433083          DOI: 10.1136/gut.28.7.903

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  20 in total

1.  Severe intrahepatic cholestasis in primary amyloidosis: a report of four cases and a review of the literature.

Authors:  A Rubinow; R S Koff; A S Cohen
Journal:  Am J Med       Date:  1978-06       Impact factor: 4.965

2.  The use of proteolytic enzymes to improve immunoglobulin staining by the PAP technique.

Authors:  B L Mepham; W Frater; B S Mitchell
Journal:  Histochem J       Date:  1979-05

3.  Primary amyloidosis and acute leukemia associated with melphalan therapy.

Authors:  R A Kyle; R V Pierre; E D Bayrd
Journal:  Blood       Date:  1974-09       Impact factor: 22.113

4.  The liver in amyloidosis.

Authors:  M Levy; A Polliack; M Lender; M Eliakim
Journal:  Digestion       Date:  1974       Impact factor: 3.216

5.  Amyloidosis of the liver causing jaundice.

Authors:  R Cox
Journal:  Postgrad Med J       Date:  1982-03       Impact factor: 2.401

6.  Immunoperoxidase techniques: practical and theoretical aspects.

Authors:  C R Taylor
Journal:  Arch Pathol Lab Med       Date:  1978-03       Impact factor: 5.534

7.  Huge hepatomegaly, jaundice and portal hypertension due to amyloidosis of the liver.

Authors:  P Melkebeke; J Vandepitte; R Hannon; J Fevery
Journal:  Digestion       Date:  1980       Impact factor: 3.216

8.  Intrahepatic cholestasis with predominant pericentral deposition in systemic amyloidosis.

Authors:  S D Finkelstein; V L Fornasier; W Pruzanski
Journal:  Hum Pathol       Date:  1981-05       Impact factor: 3.466

9.  Primary systemic amyloidosis: comparison of melphalan and prednisone versus placebo.

Authors:  R A Kyle; P R Greipp
Journal:  Blood       Date:  1978-10       Impact factor: 22.113

10.  Treatment of experimental murine amyloidosis with dimethyl sulfoxide.

Authors:  I Kedar; M Greenwald; M Ravid
Journal:  Eur J Clin Invest       Date:  1977-04       Impact factor: 4.686

View more
  7 in total

1.  A case of fatal intrahepatic cholestasis with primary AL amyloidosis: is early diagnosis possible?

Authors:  Shinichiro Takao; Kosuke Tanaka; Masayuki Miyazaki; Masatake Tanaka; Tomoko Ohashi; Masaki Kato; Kazuhiro Kotoh; Shinichi Aishima; Ryoichi Takayanagi
Journal:  Clin J Gastroenterol       Date:  2013-07-28

Review 2.  Hepatic failure in a case of multiple myeloma-associated amyloidosis (kappa-AL)

Authors:  T Yamamoto; N Maeda; H Kawasaki
Journal:  J Gastroenterol       Date:  1995-06       Impact factor: 7.527

3.  A case of prominent hepatic cholestasis developing to hepatic failure in lambda-AL amyloidosis.

Authors:  K Dohmen; M Nagano; R Iwakiri; Y Yamano; Y Kikuchi; M Mizoguchi; Y Iwata; Y Mori; H Ishibashi
Journal:  Gastroenterol Jpn       Date:  1991-06

4.  Progressive liver failure in a patient with adult Niemann-Pick disease associated with generalized AL amyloidosis.

Authors:  H Zhou; R P Linke; H E Schaefer; W Möbius; U Pfeifer
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 5.  Primary amyloidosis and severe intrahepatic cholestatic jaundice.

Authors:  R A Peters; G Koukoulis; A Gimson; B Portmann; D Westaby; R Williams
Journal:  Gut       Date:  1994-09       Impact factor: 23.059

Review 6.  Rapidly progressive obstructive jaundice due to Congo red negative amyloidosis.

Authors:  B M McClements; J H Shanks; C M Hill; C H Cameron; M E Callender
Journal:  Ulster Med J       Date:  1991-10

7.  Systemic Reactive Amyloidosis Associated with Castleman's Disease.

Authors:  Vinaya Gaduputi; Hassan Tariq; Kanthi Badipatla; Ariyo Ihimoyan
Journal:  Case Rep Gastroenterol       Date:  2013-11-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.